US Stock MarketDetailed Quotes
KAPA Kairos Pharma
- 1.540
- -0.110-6.67%
Close Nov 29 13:00 ET
- 1.540
- 0.0000.00%
Post 17:01 ET
19.78MMarket Cap-7333P/E (TTM)
1.630High1.530Low22.17KVolume1.630Open1.650Pre Close35.65KTurnover1.43%Turnover RatioLossP/E (Static)12.85MShares4.00052wk High5.95P/B2.39MFloat Cap1.22052wk Low--Dividend TTM1.55MShs Float4.000Historical High--Div YieldTTM6.07%Amplitude1.220Historical Low1.607Avg Price1Lot Size
Kairos Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -2,319.78%-2.02M | -147.06%-168K | 550.00%36K | 122.95%81K | 195.65%66K | 275.00%91K | 19.05%-68K | 94.59%-8K | 14.32%-353K | -69K |
| Net income from continuing operations | -235.58%-1.05M | -7.20%-253K | -121.23%-323K | -72.57%-1.81M | -470.41%-1.12M | -33.33%-312K | 38.70%-236K | 37.87%-146K | 51.05%-1.05M | ---196K |
| Depreciation and amortization | 0.00%40K | 0.00%40K | 0.00%40K | 0.00%160K | 0.00%40K | 0.00%40K | 0.00%40K | 0.00%40K | 63.27%160K | --40K |
| Other non cash items | 6,470.00%657K | 90.00%19K | 100.00%20K | -86.27%56K | 160.00%26K | -88.89%10K | -96.00%10K | -82.76%10K | 183.33%408K | --10K |
| Change In working capital | -581.30%-1.7M | -77.97%26K | 239.77%299K | 492.25%764K | 166.23%205K | 578.85%353K | 972.73%118K | 900.00%88K | -89.17%129K | --77K |
| -Change in prepaid assets | -22.22%7K | 122.22%2K | 35.29%-11K | ---8K | 80.00%9K | 80.00%9K | -325.00%-9K | -21.43%-17K | --0 | --5K |
| -Change in payables and accrued expense | -155.52%-191K | -81.10%24K | 195.24%310K | 498.45%772K | 172.22%196K | 631.91%344K | 1,714.29%127K | 3,400.00%105K | -89.17%129K | --72K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -2,319.78%-2.02M | -147.06%-168K | 550.00%36K | 122.95%81K | 195.65%66K | 275.00%91K | 19.05%-68K | 94.59%-8K | 14.32%-353K | ---69K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | ||||||||||
| Cash from discontinued investing activities | ||||||||||
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2,428.57%5.22M | 361.40%149K | -23.61%-89K | -159.27%-425K | -323.53%-72K | -217.28%-224K | -118.81%-57K | -130.00%-72K | 23.62%717K | -17K |
| Net issuance payments of debt | --40K | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 171.21%895K | --0 |
| Net other financing activities | -55.36%-348K | 182.46%47K | -23.61%-89K | -138.76%-425K | -323.53%-72K | -558.82%-224K | 51.28%-57K | -620.00%-72K | ---178K | ---17K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 2,428.57%5.22M | 361.40%149K | -23.61%-89K | -159.27%-425K | -323.53%-72K | -217.28%-224K | -118.81%-57K | -130.00%-72K | 23.62%717K | ---17K |
| Net cash flow | ||||||||||
| Beginning cash position | -90.95%21K | -88.80%40K | -78.72%93K | 498.63%437K | -81.07%99K | -39.58%232K | 116.36%357K | 498.63%437K | 421.43%73K | --523K |
| Current changes in cash | 2,503.01%3.2M | 84.80%-19K | 33.75%-53K | -194.51%-344K | 93.02%-6K | -195.68%-133K | -157.08%-125K | -186.96%-80K | 516.95%364K | ---86K |
| End cash Position | 3,149.49%3.22M | -90.95%21K | -88.80%40K | -78.72%93K | -78.72%93K | -81.07%99K | -39.58%232K | 116.36%357K | 498.63%437K | --437K |
| Free cash flow | -2,319.78%-2.02M | -147.06%-168K | 550.00%36K | 122.95%81K | 195.65%66K | 275.00%91K | 19.05%-68K | 94.59%-8K | 14.32%-353K | ---69K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
